More than two million Americans have been screened for colorectal cancer using Exact Sciences‘ Cologuard, the company announced today.

“Cologuard is changing how Americans get screened for colorectal cancer and, importantly, helping many people do so for the first time,” Exact Sciences CEO Kevin Conroy said in a statement. “Reaching this milestone, just a year after the first million patients screen with Cologuard, means more patients and healthcare providers are empowered by early detection when colorectal cancer is more treatable.”

As previously reported, since 2014, more than 150,000 healthcare providers have ordered Cologuard and the company predicts it has helped detect as many as 9,400 early-stage cancers and approximately 64,000 pre-cancerous polyps.

National Colorectal Cancer Awareness Month begins in March.